Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGC NASDAQ:CRON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$0.96-1.2%$1.02$0.84▼$2.38$435.50M0.794.74 million shs1.61 million shsCRONCronos Group$2.75$2.73$1.92▼$3.43$1.03B0.89854,565 shs566,992 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-1.15%0.00%-4.00%-11.93%-15.04%CRONCronos Group0.00%-0.36%+2.61%+7.00%+31.58%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$0.96-1.2%$1.02$0.84▼$2.38$435.50M0.794.74 million shs1.61 million shsCRONCronos Group$2.75$2.73$1.92▼$3.43$1.03B0.89854,565 shs566,992 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-1.15%0.00%-4.00%-11.93%-15.04%CRONCronos Group0.00%-0.36%+2.61%+7.00%+31.58%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 2.17HoldN/AN/ACRONCronos Group 2.20Hold$2.30-16.36% DownsideCurrent Analyst Ratings BreakdownLatest CGC and CRON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/29/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/15/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/1/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/29/2026CRONCronos Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)5/18/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/12/2026CRONCronos Group TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/20/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$251.01M1.72N/AN/A$1.13 per share0.85CRONCronos Group$146.59M7.00$0.01 per share219.35$3.00 per share0.92Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$190.29M-$0.59N/AN/AN/A-75.27%-26.95%-17.20%8/7/2026 (Estimated)CRONCronos Group-$9.45M$0.01275.28N/AN/A-1.14%-1.26%-1.20%8/6/2026 (Estimated)Latest CGC and CRON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2026Q1 2027CGCCanopy Growth-$0.04N/AN/AN/A$58.21 millionN/A8/6/2026Q2 2026CRONCronos Group$0.01N/AN/AN/A$44.20 millionN/A6/15/2026Q4 2026CGCCanopy Growth-$0.06-$0.17-$0.11-$0.05$53.43 million$51.22 million5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 million$45.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.313.342.64CRONCronos GroupN/A21.8720.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth0.16%CRONCronos Group7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth1,128448.42 million447.70 millionOptionableCRONCronos Group450373.03 million343.94 millionOptionableCGC and CRON HeadlinesRecent News About These CompaniesWhy Is Cronos Group (NASDAQ:CRON) Extending CanAdelaar Deal?July 7, 2026 | kalkinemedia.comKTop Canadian Marijuana Stock Picks For Investors TodayJuly 6, 2026 | marijuanastocks.comMCronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in CanadaJune 30, 2026 | finance.yahoo.comCronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in CanadaJune 30, 2026 | globenewswire.comCRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?June 24, 2026 | zacks.comCronos Group Inc. Announces Results of 2026 Annual Meeting of ShareholdersJune 22, 2026 | finance.yahoo.comCronos Group Inc. Announces Results of 2026 Annual Meeting of ShareholdersJune 22, 2026 | globenewswire.comShould Cronos Group’s Expanded US$50 Million Buyback Shape Capital Allocation Views For Cronos (TSX:CRON) Investors?June 19, 2026 | finance.yahoo.com3 Marijuana Stocks Investors Can See Returns On Before The End Of The YearJune 17, 2026 | marijuanastocks.comMCronos Announces Extension of Share Repurchase Program to the Toronto Stock ExchangeJune 16, 2026 | finance.yahoo.comCronos Extends a Share Repurchase Program to the Toronto Stock ExchangeJune 16, 2026 | finance.yahoo.comCronos Announces Extension of Share Repurchase Program to the Toronto Stock ExchangeJune 16, 2026 | globenewswire.comSpinach® is the Number One Vape Brand in CanadaJune 11, 2026 | finance.yahoo.comSpinach® is the Number One Vape Brand in CanadaJune 11, 2026 | globenewswire.com3 Canadian Marijuana Stocks That Could Help You Make MoneyJune 3, 2026 | marijuanastocks.comMAndrew Left Found Guilty in Case That Spooked Short SellersJune 2, 2026 | finance.yahoo.comShort Seller Andrew Left Found Guilty of Securities FraudJune 1, 2026 | finance.yahoo.comTSX Penny Stocks To Watch In June 2026June 1, 2026 | finance.yahoo.comCronos Group Inc (CRON) Stock Was Rising. Can the Rally Continue After Q1 Results?May 31, 2026 | finance.yahoo.comCannabis, Wellness And Beverages: Three Names To WatchMay 28, 2026 | kalkinemedia.comKNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCGC and CRON Company DescriptionsCanopy Growth NASDAQ:CGC$0.96 -0.01 (-1.15%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$0.96 0.00 (-0.10%) As of 07/13/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$2.75 0.00 (0.00%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$2.74 -0.02 (-0.55%) As of 07/13/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
